Search for: "Amgen, Inc. v. Hoechst Marion Roussel, Inc." Results 1 - 20 of 41
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
27 Mar 2007, 3:29 pm
Hoechst Marion Roussel, Inc., et al. [read post]
15 May 2007, 6:59 am
Hoechst Marion Roussel Inc. and Transkaryotic Therapies Inc., 06-1291. [read post]
27 Nov 2006, 5:18 am
Hoechst Marion Roussel (05-1157 ) - November 22, 2006(Petition for en banc rehearing denied)Since the Federal Circuit decided in Cybor Corp v. [read post]
26 Aug 2021, 1:05 pm by Lawrence B. Ebert
Hoechst Marion Roussel, Inc., 314 F.3d 1313, 1330 (Fed. [read post]
12 Dec 2008, 8:42 am
Hoechst Marion Roussel, Inc., 457 F.3d 1293, 1306-07 (Fed. [read post]
2 Feb 2014, 9:40 am by Dennis Crouch
Hoechst Marion Roussel, Inc., 314 F.3d 1313, 1342 (Fed. [read post]
8 Mar 2023, 2:51 pm by Lawrence B. Ebert
Hoechst Marion Roussel, Inc., 314 F.3d 1313, 1330 (Fed. [read post]
1 Apr 2011, 12:42 pm by Lawrence B. Ebert
Hoechst Marion Roussel, Inc., 314 F.3d 1313, 1331-33 (Fed. [read post]
26 Nov 2015, 8:12 am
 Per the precedent set in Kirin-Amgen Inc v Hoechst Marion Roussel Ltd [2004] UKHL 46 (and other cases since), the question is "...what the person skilled in the art would have understood the Patentee to be using the language of the claim to mean". [read post]
26 Jul 2017, 3:49 am by Miquel Montañá
As explained in paragraph 42 of this judgment, in paragraph 37 of Kirin-Amgen Inc v Hoechst Marion Roussel Ltd [2005] RPC 9, Lord Hoffmann explained that the doctrine of equivalents had been developed in the United States. [read post]
26 Jul 2017, 3:49 am by Miquel Montañá
As explained in paragraph 42 of this judgment, in paragraph 37 of Kirin-Amgen Inc v Hoechst Marion Roussel Ltd [2005] RPC 9, Lord Hoffmann explained that the doctrine of equivalents had been developed in the United States. [read post]